HLB bioStep Co.,Ltd. (KOSDAQ:278650)
6,360.00
-125.00 (-1.93%)
At close: Apr 23, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 107.65 billion as of April 24, 2026. Its market cap has decreased by -28.21% in one year.
Market Cap
107.65B
Enterprise Value
99.73B
Revenue
74.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,360.00
Market Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 107.65B, a decrease of -57.69%. That is a compound annual growth rate of -12.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 107.65B | -12.36% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 645.66B |
| DreamCIS | 123.38B |
| P&K Skin Research Center | 70.47B |
| WOOJUNG BIO | 53.10B |
| C&R Research | 45.92B |
| DT&CRO CO. | 44.62B |
| SLS BIO | 26.89B |
| BioInfra | 20.80B |